Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

RVX-208

Inh 1044870-39-4 2-[4-(2-hydroxyethoxy)-3,5-dimethylphenyl]-5,7-dimethoxy-4(3H)-quinzolinone
N° du produit ABIN7233283
  • Application
    Inhibition (Inh)
    Fonction
    BET bromodomain inhibitor
    Attributs du produit
    RVX-208 is a potent BET bromodomain antagonist with IC50 of 0.510 μM for BD2, with approximately 170-fold selectivity over BD1. Increases apolipoprotein A-1 and HDL cholesterol in vitro and in vivo. Reduces atherosclerosis.
    Pureté
    >98 %
    Chemical Name
    2-[4-(2-hydroxyethoxy)-3,5-dimethylphenyl]-5,7-dimethoxy-4(3H)-quinzolinone
    Formula
    C20H22N2O5
    Solubility
    Soluble in DMSO (up to 75 mg/ml) or in Ethanol (up to 4 mg/ml).
  • Restrictions
    For Research Use only
  • Format
    Powder
    Précaution d'utilisation
    GHS – Classification
    Not a dangerous substance
    Stock
    -20 °C
  • Sujet
    Epigenetics,Posttranslational modification,Bromodomain,Atherosclerosis,Chromatin,Cholesterol metabolism
    Poids moléculaire
    370.41
    Numéro CAS
    1044870-39-4
Vous êtes ici:
Support technique